Cutler Group’s HUMANIGEN, INC. HGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,400
Closed -$26K 5753
2022
Q2
$26K Sell
25,400
-47,600
-65% -$107K ﹤0.01% 2473
2022
Q1
$68K Buy
73,000
+71,500
+4,767% +$191K ﹤0.01% 2000
2021
Q4
$16K Sell
1,500
-2,500
-63% -$14.6K ﹤0.01% 3331
2021
Q3
$28K Sell
4,000
-2,100
-34% -$29.5K ﹤0.01% 3053
2021
Q2
$21K Buy
6,100
+1,300
+27% +$23.7K ﹤0.01% 3280
2021
Q1
$13K Buy
4,800
+3,000
+167% +$54.8K ﹤0.01% 3606
2020
Q4
$2K Buy
+1,800
New +$21.5K ﹤0.01% 4300

Other funds holding HGEN

Cutler Group's HGEN Position: Q1 2023 in Review

Cutler Group sold out of HUMANIGEN, INC. (HGEN) in Q1 2023, closing a stake of 5,239 shares.

Cutler Group first reported a position in HGEN in Q1 2021 and held it in 8 quarters. The position peaked at $454K in Q1 2022. 42 funds tracked by Wall St. Rank hold HGEN as of Q1 2023.

  • Cutler Group reported no remaining HUMANIGEN, INC. position as of Q1 2023 after selling out during the quarter.
  • Cutler Group sold 5,239 HUMANIGEN, INC. shares in Q1 2023.
  • Cutler Group first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 8 quarters.
  • Cutler Group's HUMANIGEN, INC. position peaked at $454K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.